Viewing StudyNCT00292084



Ignite Creation Date: 2024-05-05 @ 4:40 PM
Last Modification Date: 2024-10-26 @ 9:23 AM
Study NCT ID: NCT00292084
Status: COMPLETED
Last Update Posted: 2008-01-21
First Post: 2006-02-13

Brief Title: An Extension Study to Evaluate the Safety and Efficacy of Celgosivir and Peginterferon Alfa-2b With or Without Ribavirin in Patients With Chronic Hepatitis C Genotype 1 Infection
Sponsor: BioWest Therapeutics Inc
Organization: BioWest Therapeutics Inc

Organization Data

Organization: BioWest Therapeutics Inc
Class: INDUSTRY
Study ID: HCV-05-004
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: BioWest Therapeutics Inc
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: None
Responsible Party Affiliation: None
Old Name: Jim Pankovich
Old Organization: MIGENIX Inc

Collaborators